Section Arrow
Quote
TAK.NYSE
- Takeda Pharmaceutical Company Limited
Quotes are at least 15-min delayed:2026/02/15 13:11 EST
Regular Hours
Last
 18.46
+0.09 (+0.49%)
Day High 
18.5 
Prev. Close
18.37 
1-M High
18.45 
Volume 
3.09M 
Bid
18.23
Ask
18.72
Day Low
18.36 
Open
18.37 
1-M Low
15.78 
Market Cap 
58.03B 
Currency 美元 
P/E 79.42 
%Yield 3.58 
10-SMA 17.81 
20-SMA 17.12 
50-SMA 15.95 
52-W High 18.45 
52-W Low 12.99 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
35.34/220.99
Enterprise Value
4,024.36B
Balance Sheet
Book Value Per Share
15.66
Cash Flow
Cash Flow Yield
0.13
Income Statement
Total Revenue
1,508.93B
Operating Revenue Per Share
8.80
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health16.3+0.5+3.16%29.91PE
CGCCanopy Growth Corp1.08+0.05+4.85%-- 
HLNHaleon plc11.2+0.04+0.36%24.53PE
VTRSViatris15.77-0.02-0.13%-- 
AKBAAkebia Therapeutics1.21-0.15-11.03%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.